RecruitingNot ApplicableNCT04402346

Radiofrequency-assisted Transection of the Pancreas vs Stapler

Radiofrequency-assisted Transection of the Pancreas vs Stapler. A Phase III Randomized Clinical Trial.


Sponsor

Patricia Sanchez Velazquez

Enrollment

110 participants

Start Date

Feb 15, 2021

Study Type

INTERVENTIONAL

Conditions

Summary

Main objective: The main end-point of this study is to compare in a randomized clinical trial that radiofrequency-assisted pancreas transection (RF) reduces the incidence of postoperative pancreatic fistula (POPF) compared to the classical method of transection (stapler). As secondary end-points, other clinical and demographic variables of the patients will be evaluated (sex, age, ASA classification, consistency of the pancreas, as well as the type of procedure, open or laparoscopic surgery, estimated intraoperative bleeding, pancreatic duct size, duration of intervention, type of tumor and quality of lymphatic resection). Methodology: Phase III prospective multicenter study in patients undergoing distal pancreatectomy for any origin. All consecutive patients who undergo a distal pancreatectomy for any cause in a multicenter setting will be included. A simple randomization of the participants to the RFA group or to the control group (stapler) will be carried out. The incidence of pancreatic fistula will be assessed as main variable; predictive multivariable models with multiple regression for quantitative variables, logistic regression for categorical variables and Cox regression for survival analyzes. In addition to histological study, molecular analysis of resection specimen and clinical and radiological follow-up with volumetry of necrosis in the area of post-pancreatectomy transection will be performed.


Eligibility

Min Age: 18 Years

Plain Language Summary

Simplified for easier understanding

This study compares two surgical methods for removing part of the pancreas — one that uses a radiofrequency device to cut the pancreas versus the standard stapler technique — to see which method causes fewer complications like leaks after surgery. **You may be eligible if...** - You have a tumor in the pancreas (benign or cancerous, solid or cystic) - You are scheduled for surgery to remove the tail end of the pancreas (distal pancreatectomy) - You are 18 or older **You may NOT be eligible if...** - You need surgery at the neck of the pancreas (a different location) - Your overall health is too poor for surgery (ASA grade 4 or higher, meaning very severe systemic illness) - You have not given informed consent Talk to your doctor to see if this trial is right for you.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

PROCEDURERadiofrequency-assisted pancreas transection

Transection of the pancreas in distal pancreatectomy by applying a radio frequency device

PROCEDUREStapler assisted pancreas transection

Transection of the pancreas in distal pancreatectomy by applying a stapler device with/without seamguard


Locations(1)

Parc de Salut Mar de Barcelona- Hospital del Mar

Barcelona, Catalonia, Spain

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT04402346


Related Trials